Lenalidomide in myelodysplastic syndromes.
List
Alan F
AF
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Fla., USA.
D002986:Clinical Trials as Topic; D017353:Gene Deletion; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000077269:Lenalidomide; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000235:genetics; D012074:Remission Induction; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
D007155:Immunologic Factors; D013792:Thalidomide; D000077269:Lenalidomide